1.0
18 June 2024
Former employee, more than 1 year
Basel
Recommend
CEO approval
Business outlook
Pros
Nothing good only experience gained on how to avoid theming future
Cons
No rules, chaos, no compliance led to a mass exit of Clinical Study Managers in the same year. Bullying and burnouts